Skip to main content

Table 2 Comparison of clinical and QCT parameters between different groups

From: Relationship between body composition and bone mineral density in postmenopausal women with type 2 diabetes mellitus

variables

T2DM

non-T2DM

P

P1

P2

P3

P4

 

50-65y (n = 88)

 > 65y (n = 89)

50-65y (n = 75)

 > 65y (n = 61)

Age (years)

59.00 (53.00, 61.00)

73.00 (69.50, 78.00)

60.00 (56.00, 62.00)

76.00 (70.00, 79.50)

 < 0.001

 < 0.001

 < 0.001

0.366

0.550

BMI (kg/m2)

24.25 (21.65, 27.37)

24.90 (23.20, 27.95)

22.80 (21.10, 25.40)

23.80 (21.00, 25.45)

 < 0.001

0.086

0.442

0.020

0.003

m-BMD (mg/cm3)

92.30 (66.50, 117.18)

55.00 (41.15, 74.55)

79.20 (57.50, 103.50)

37.50 (22.30, 59.90)

 < 0.001

 < 0.001

 < 0.001

0.064

0.002

BMD-L1 (mg/cm3)

98.65 (73.98, 126.43)

61.10 (44.50, 82.50)

88.30 (59.00, 105.70)

44.90 (27.60, 63.90)

 < 0.001

 < 0.001

 < 0.001

0.050

0.003

BMD-L2 (mg/cm3)

90.90 (65.45, 116.13)

54.80 (36.60, 72.50)

83.70 (54.20, 111.80)

37.00 (12.50, 56.65)

 < 0.001

 < 0.001

 < 0.001

0.090

0.001

BMD-L3 (mg/cm3)

88.70 (63.43, 111,23)

54.40 (38.30, 69.25)

76.00 (58.00, 97.00)

36.80 (16.80, 58.75)

 < 0.001

 < 0.001

 < 0.001

0.100

0.005

VFM (g)

35.25 (24.95, 44.98)

42.70 (33.90, 62.45)

25.30 (18.00, 32.40)

31.50 (19.45, 50.55)

 < 0.001

0.001

0.003

 < 0.001

 < 0.001

VFA (cm2)

132.70 (100.15, 184.20)

160.90 (133.80, 229.45)

102.70 (77.20, 148.60)

134.50 (102.00, 194.45)

 < 0.001

0.001

0.001

0.001

0.003

SFM (g)

38.90 (27.95, 54.58)

40.60 (28.35, 55.45)

27.10 (19.60, 41.30)

33.10 (14.95, 49.70)

0.001

0.861

0.323

0.001

0.031

SFA (cm2)

145.10 (110.68, 201.70)

151.50 (106.55, 206.00)

121.10 (92.20, 181.50)

145.10 (93.40, 199.85)

0.198

NA

NA

NA

NA

PMM (g)

5.60 (4.80, 7.15)

5.70 (4.35, 7.30)

5.60 (4.30, 6.80)

5.30 (4.25, 7.15)

0.503

NA

NA

NA

NA

PMA (cm2)

18.95 (16.20, 23.05)

18.50 (15.75, 23.90)

19.60 (16.90, 22.90)

19.30 (14.85, 24.00)

0.845

NA

NA

NA

NA

  1. Values are presented as median (interquartile range). Kruskal–Wallis test was used for analysis
  2. T2DM Type 2 diabetes mellitus, BMI Body mass index, m-BMD Mean bone mineral density, BMD-L1 Bone mineral density of lumbar 1 vertebral body, BMD-L2 Bone mineral density of lumbar 2 vertebral body, BMD-L3 Bone mineral density of lumbar 3 vertebral body, VFM Visceral fat mass, VFA Visceral fat area, SFM Subcutaneous fat mass, SFA Subcutaneous fat area, PMM Psoas major mass, PMA Psoas major area
  3. P1: 50-65y vs > 65y in T2DM group
  4. P2: 50-65y vs > 65y in non-T2DM group
  5. P3: 50-65y in T2DM group vs 50-65y in non-T2DM group
  6. P4: > 65y in T2DM group vs > 65y in non-T2DM group